z-logo
Premium
Drug‐drug interaction between warfarin and statins: A Danish cohort study
Author(s) -
Engell Anna E.,
Svendsen Andreas L.O.,
Lind Bent S.,
Andersen Christen L.,
Andersen John S.,
Willadsen Tora G.,
Persson Frederik,
Pottegård Anton
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14428
Subject(s) - rosuvastatin , warfarin , atorvastatin , simvastatin , medicine , statin , drug interaction , drug , cohort , pharmacology , atrial fibrillation
Initiation of statin treatment is suggested to increase the international normalised ratio (INR) among warfarin users. However, available data is limited and conflicting. We conducted a register‐based cohort study to evaluate the drug‐drug interaction between warfarin and statins. By linking data on INR measurements and filled prescriptions, we identified warfarin users 2000‐2015 initiating simvastatin (n = 1363), atorvastatin (n = 165) or rosuvastatin (n = 23). Simvastatin initiation led to an increase in mean INR from 2.40 to 2.71, with INRs peaking after 4 weeks, corresponding to a mean change of 0.32 (95%CI 0.25‐0.38). High‐dose and low‐dose simvastatin led to comparable changes (mean change 0.33 vs 0.29). Initiation of atorvastatin and rosuvastatin lead to INR increases of 0.27 (95%CI 0.12‐0.42) and 0.30 (95%CI ‐0.09‐0.69). In conclusion, initiation of simvastatin, atorvastatin or rosuvastatin among warfarin users led to a minor increase in INR. The magnitude of this change is for most patients likely of limited clinical relevance.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here